Biotech Stock Still 700%: What Investors Should Do Today
A biotech stock still 700% has defied gravity, even as it slumps 30% this year. Learn how to read the signals, what a...
Choosing the right rewards program can significantly impact your benefits. Learn which one suits you best.
27,579 articlesA biotech stock still 700% has defied gravity, even as it slumps 30% this year. Learn how to read the signals, what a...
Bitcoin surged past $70,000 on signs that U.S. actions against Iran would be paused for five days, sparking a broad r...
Oil climbs to the $100 level as tech stocks retreat, pushing the Nasdaq Composite lower. Investors weigh energy price...
XRP is carving a large pennant as traders eye a potential breakout this week. With volume shrinking, a move past $1.6...
A fresh Mizuho note raises Intel's price target to $124 on AI server demand, signaling renewed confidence in the turn...
Hedge fund veteran Michael Burry has added stakes in a high-dividend pharma name and a leading oilfield services comp...
As oil costs climb, ETH faces renewed pressure, illustrating a rare inverse relationship that market trackers say cou...
Through May 2026, CWB rose about 19% year-to-date, underscoring the appeal of convertible bonds as a middle ground be...
A Reagan Institute survey shows two-thirds of voters are upbeat on American-led innovation, spanning parties and gene...
Realtracs warns of a June 1 cutoff for the Zillow feed unless updated IDX rules are met. The move could remake listin...
Marvell Technology’s stock rises to a 25-year high, lifting its S&P 500 position to No. 22. Analysts point to AI-driv...
Bitcoin steadies around $63,000 after a weekend drop to the low $59,000s as CME BVX volatility futures arrive. Instit...